Janssen Ortho LLC 2006 APR View/Print

OMB No. 2010-0032
Expiration Date 01/31/2010

2006 Performance Track Annual Performance Report

Janssen Ortho LLC
A020020
Year 3 Annual Performance Report
Member Since 2001 (2nd Member Term)

SECTION A: GENERAL FACILITY INFORMATION

A.1

Name of your facility:

Janssen Ortho LLC

A.2

Name of your parent company:

Johnson & Johnson

A.3

Facility contact person for the Performance Track program:

Name:	Mr. Sandy Casillas
Title:	Environmental Supervisor
Phone:	787-272-7413
Fax:	787-272-7435
Email:	scasill2@janpr.jnj.com

A.4

Facility location:

Street Address:	Road 933 KM 0.1 Mamey Ward
Address Cont:
City:	Gurabo
State:	PR
Zip Code:	00778-9629
Mailing address (if different from above):
Mailing Address:	HC 02 Box 19250
Address Cont:	Mamey Ward
City:	Gurabo
State:	PR
Zip Code:	00778-9629
If your facility has multiple street addresses, please list any other addresses for its sites or buildings.

A.5

Facility's website address (if any):

http://www.janssen.com

A.6

Number of employees (full-time equivalents) who currently work in the facility:

More than 1,000

A.7

North American Industrial Classification System (NAICS) Code(s) that is(are) used to classify business at the facility:

334514

A.8

In your application and, perhaps, in previous annual performance reports, you described what your facility does or makes. Have there been any (additional) changes to your facility's list of products and/or activities?

Yes

If yes, please list them here:

A new manufacturing area was added were the product "Paliperidone" is manufactured

A.9

Have the environmental requirements applicable to your facility changed during this reporting period?

Yes

If yes, please describe these changes here:

We now store acetone and waste acetone in bulk. A Leak Detection and Repair (LDAR) program is required under the Resource Conservation and Recovery Act.(RCRA). Also, we submitted the Title V air emission application permit triggered by NOx.

Section B: ENVIRONMENTAL MANAGEMENT SYSTEM

B.1.a

When was an EMS assessment last conducted by an independent party at your facility?

2006

If an assessment was conducted during 2006, please provide the type (e.g., ISO 14001 certification), the scope, and the month(s) of each assessment.

Type Scope Dates

ISO 14001

This surveillance assessment included: Environmental Aspects,Legal & Other Requirements, Objectives Targets & Programs, Resources Roles Responsibilities & Authority, Documentation, Control of Documents, Operational Control, Emergency Preparedness & Response, Control of Records & Management Review.
October 2006

ISO 14001
This surveillance assessment included:
Environmental Policy, Environmental Aspects, Objectives Targets and Programs, Competence Training & Awareness, Communication, Operational Controls, Monitoring & Measurements, Evaluation of Compliance, Nonconformity Corrective and Preventive Action, Internal Audit & Management Review
February 2006

B.1.b

When was an internal EMS assessment last conducted at your facility?

2005

If an assessment was not conducted in 2006, please indicate when your next audit is scheduled.

The next internal EMS assessment is schedule for 4th quarter 2007

B.1.c

When was an internal or corporate compliance audit last conducted at your facility?

2006

If an audit was conducted during 2006, please provide the scope and the month(s) of each audit, and indicate who conducted the audit(s) (e.g., facility staff, corporate groups, third party). (Don't include audits, inspections, or site visits by regulatory or external organizations).

Scope Dates Who conducted the audit

A compliance audit was performed to verify compliance on report, permits, sampling events as part of ISO pre-assessment. February 2006 Performed by Eng. Lymaris Delgado, (staff), Eng. Marla Ciares (third party) and Eng.Charlotte Poulet (third party) who is an Environmental Professional at Ortho Biologics in Manati (PR)

B.1.d

(Optional) If you would like to describe any other audits or inspections that were conducted at your facility, please do so here.

On 03-07-06 We receive an inspector from EQB (PR) to conduct compliance inspection verifying 90 days storage area, satellite areas, manifests and other documents
On 03-13-06 We receive an inspector from the POTW (Pre-treatment Program) to conduct a compliance inspection. The WWTP was inspected and documents were requested.
On 05-04-06 We receive Mr. Adalberto Bosque from EPA (CFO) as part of the Remediation Project under the Superfund Program.
On 06-06-06 We receive an inspector from DOH to conduct a sampling on our drinking water system.
On 07-17-06 We receive an inspector from the POTW (Pre-treatment Program) to conduct a sampling of our WWTP discharge.
On 09-12-06 We receive an inspector from DOH to conduct a sampling on our drinking water system.
On 09-22-06 We receive an inspector from the POTW (Pre-treatment Program) to conduct a compliance inspection. The WWTP was inspected and documents were requested.
On 10-04-06 We receive an inspector from Natural Resource Dept.(NRD) to verify compliance with the wellwater franchise permit.
On 12-12-06 We receive two inspectors from EQB Superfund Program to supervise the sampling activities at the remediation project.
On 12-19-06 We receive an inspector from DOH to conduct a sampling on our drinking water system.

No violations were found during these goverment inspections.

B.1.e

Briefly summarize corrective actions taken and other improvements made as a result of your EMS assessments and compliance audits.

To reduce risks on potential spills of acetone we have modified the unloading approval procedure and as a result we have reduce the unloading waiting period from 3-4 days to 24-36 hrs.

B.1.f

Has your facility corrected all instances of potential non-compliance and EMS non-conformance identified during your audits and other assessments?

If no, please explain your plans to correct these instances.

Of the latest ISO 14001 assessment there is one pending non-conformance item that is schedule for completion. Based on a potential spill scenario at the acetone tank farm, it was recommended a modification of the containment area for the unloading process. A capital apropiation request was routed for approval and construction/completion is schedule for 3rd quarter 2007.

B.1.g

When was the last Senior Management review of your EMS completed?

November 06

Who was the senior manager present at the review?

Name: Mr. Ivan Cartagena

Title: General Manager

B.2.a

ISO 14001 Certification. Is your facility currently certified to ISO 14001?

Yes

B.2.b

Is your facility a Responsible Care-certified facility?

B.3 Environmental Aspects Identification. When did your facility last conduct a systematic identification and/or review of your environmental aspects?

October 06

SECTION C: ENVIRONMENTAL PERFORMANCE RESULTS

C.1 COMMITMENT 1

Janssen Ortho LLC's first commitment is to reduce the facility's total water use.

C.1.a Briefly describe your activities and achievements related to this commitment or, if relevant, any circumstances that delayed progress this year.

We continued to reuse water from remediation project in our utilities such as cooling towers therefore avoiding potable water consumption. We also initiated the wastewater treatment plant water reuse project, which will allow us to reuse most of the WWTP discharge and consequently reducing the potable water usage. Normalization Factor is based on 4804MM Units produced in 2006 vs 4755MM Units produced in 2003

Activities Conducted During 2005:
Approximately 40% of water discharge of the remediation treatment system have been reused internally for non-potable purposes. In addition, several projects (e.g., monitoring of water usage at different areas) and/or initiatives addressed to the reduction in water consumption were implemented.

Activities Conducted During 2004:
Approximately 40% of water discharge of the remediation treatment system have been reused internally for non-potable purposes.
In addition a revision of the water bills revealed that JOLLC was paying various invoices of facilities formerly use by Janssen. Various accounts were cancelled and credits received from the actual users.
Normalization factor is based on 4755 MM Units produced in 2003 vs 5111 MM units produced in 2004.

C.1.b Please report your facility's actual performance.

Performance Data

Baseline Year 1 Year 2 Year 3 Perform.

Calendar Year 2003 2004 2005 2006 Goal Units

Actual Quantity (per year) 54,288,263 49,182,538 45,111,857 47,116,265 n/a Gallons

Specify other:

C.1.c Normalized progress toward goal.

Normalized Total Baseline Year 1 Year 2 Year 3 Perform.
Goal Units

Normalizing Factor 1.0 1.07 1.07 1.01

Normalized Quantity 54,288,263 45,964,988.79 42,160,614.02 46,649,767.33 52,659,615 Gallons

Specify other:

Basis for your Normalizing Factor: The normalizing factor will be the tablets manufactured.

C.1.e Please list any other EPA voluntary programs to which you are reporting these data.

C.2 COMMITMENT 2

Janssen Ortho LLC's second commitment is to reduce the facility's materials use. This data is aggregated with that of three other PSGA manfucturing facilities (Ortho Pharmaceutical and Ortho Biologics of Manati, PR and Ortho Pharmaceutical in Raritan, NJ). The data is included in the report for the Raritan facility.

C.2.a Briefly describe your activities and achievements related to this commitment or, if relevant, any circumstances that delayed progress this year.

The facility established a goal for 2007 on the EI metric and was agreed on by the facility's leadership group. This metric is presented on the staff meetings. Normalization factor is based on 4755 MM Units produced in 2003 vs 4804 MM Units produced in 2006

Activities Conducted During 2005:
Site is focusing in the Design for the Environment (DfE) approach required by Johnson & Johnson for Planet 2010 Goals and the Efficiency Index (EI), which is a metric that takes into consideration the handling of materials received, quality control effective techniques/practices, manufacturing processes, storage of final products, etc. These practices and programs have been integrated within the Process Excellence initiatives. These initiatives seek for opportunities on process improvement, increase yield, reduce cycle time, control employee exposure and operating costs. Controlling all those have a positive impact in the site environmental performance. The Site's EI for Year 2005 was one of the highest's within the organization.

Activities Conducted During 2004:
Site embraces the six sigma, lean thinking and design excellence approach. It is basically been integrated within the Process Excellence initiatives. This initiative seeks for opportunities on process improvement, increase yield, reduce cycle time, control employee exposure and operating costs. Controlling all those have a positive impact in the site environmental performance. Projects that have impact this goals are: Granulators yield improvement by 2-5%, Improvement in compressors stage thus eliminating rejects due to broken tablets, Automation of packaging lines, etc.
Normalization factor is based on 4755 MM Units produced in 2003 vs 5111 MM units produced in 2004.

C.2.b Please report your facility's actual performance.

Performance Data

Baseline Year 1 Year 2 Year 3 Perform.

Calendar Year 2003 2004 2005 2006 Goal Units

Actual Quantity (per year) 0 0 0 0 n/a Pounds

Specify other:

C.2.c Normalized progress toward goal.

Normalized Total Baseline Year 1 Year 2 Year 3 Perform.
Goal Units

Normalizing Factor 1.0 1.07 1.07 1.01

Normalized Quantity 0 0.00 0.00 0.00 0 Pounds

Specify other:

Basis for your Normalizing Factor:
N/A

C.2.e Please list any other EPA voluntary programs to which you are reporting these data.

C.3 COMMITMENT 3

Janssen Ortho LLC's third commitment is to reduce the facility's generation of non-hazardous waste.

C.3.a Briefly describe your activities and achievements related to this commitment or, if relevant, any circumstances that delayed progress this year.

Disposable protection garments at the manufacturing area were replaced by reusable ones. This was part of a greenbelt project were cost avoidance was impacted significantly. Another activity for waste reduction is the reuse of empty fiber drums at other J&J facilities therefore avoiding discarting them. Normalization factor is based on 4755 MM Units produced in 2003 and 4804MM produced in 2006

Note: Waste to landfill for 2005 changed from 275,640 lbs to 1,095,630 lbs.

Activities Conducted During 2005:
The site is identifying and implementing reuse and recycling processes that are helping the achievement of the reduction of non-hazardous waste disposal. In addition, since the Efficiency Index and the Design for the Environment initiatives are being implemented, this have aid in the reduction of waste associated with raw materials and others that indirectly are associated with the disposal of discarded materials (e.g., plastic bags, drums).

Activities Conducted During 2004:
Although a slight increase in the overall volume of waste was experienced during this year, site made significant efforts in manageing the waste through environmental-friendly management methods. Over 45% increase in recyclables materials compare with year 2003. Overall waste managemet practices represents that 35.04% of our non-hazardous waste is managed by preferred management method as described by J&J (i.e. reuse, recycle, incineration with energy recovery, etc.)
Normalization factor is based on 4755 MM Units produced in 2003 vs 5111 MM units produced in 2004.

C.3.b Please report your facility's actual performance.

Performance Data

Waste Management Method Baseline Year 1 Year 2 Year 3 Units

2003 2004 2005 2006

Reused/recycled off-site

Specify other:
497,661 728,380 674,059 545,188 Pounds

Specify other:

Incineration

Specify other:
532,483 691,958 343,584 104,635 Pounds

Specify other:

Landfill

Specify other:
1,050,715 877,320 1,095,630 713,259 Pounds

Specify other:

Other management

Specify other: Biological Treatment
78,373 2,700 53,240 0 Pounds

Specify other:

Other management

Specify other:
0 0

Specify other:

C.3.c Summarized progress toward goal.

Actual Total Baseline Year 1 Year 2 Year 3 Perform.
Goal Units

Total Non Hazardous Waste 1,079.62 1,150.18 1,083.26 681.54 n/a Tons

Specify other:

Normalized Total Baseline Year 1 Year 2 Year 3 Perform.
Goal Units

Normalizing Factor 1.0 1.07 1.07 1.01

Total Non Hazardous Waste 1,079.62 1,074.93 1,012.39 674.79 1,058.02 Tons

Specify other:

Basis for your Normalizing Factor:
Normalizing factor shall be total production in units of tablets.

C.3.e Please list any other EPA voluntary programs to which you are reporting these data.

C.4 COMMITMENT 4

Janssen Ortho LLC's fourth commitment is to reduce the facility's generation of hazardous waste.

C.4.a Briefly describe your activities and achievements related to this commitment or, if relevant, any circumstances that delayed progress this year.

We provide continuous awareness on waste minimization practices, pollution prevention and waste segregation as part of the orientations we provide to employees handleing HW.

Activities Conducted During 2005:
A reduction in hazardous waste was due to the implementation of the Design for the Environment tool, the Efficiency Index, and the practice of weighting the materials instead of use the volumes of the different containers.

DFE is a systematic process to identify and minimize the environmental impacts of products and processes throughout their entire life cycles. Has help the Environmental aspects in: Reducing risk; Reduce costs; Reduce time-to-profit; Eliminate the use of banned materials; Enhance Disassembly/Reuse/Recycle
Gain competitive advantage.

Efficiency Index or Ei, is an internal metric from the Pharmaceutical Sector within J&J, which is a way to measure how effectively we convert raw materials into finished goods. The ultimate goal is an Ei of 100%, which means that we are using all of our raw materials in our manufacturing processes with no waste. The closer we get to Ei 100 the better we are doing. Improving this metric we were able to reduce the generatioon of hazardous waste associated to cleaning process, such as Alcohol and rags, among others.

Activities Conducted During 2004:
An increase in volume of operation have impacted the generation of hazardous waste at the site. Particularly the integration of Quality Assurance testing from other pharmaceutical facilities of PR into the Janssen Ortho LLC operation have impacted this measurement. This testings required usage of solvents that shall be disposed of as hazardous waste. Opportunities for improvement will be evaluated during this year.
Normalization factor is based on 4755 MM Units produced in 2003 vs 5111 MM units produced in 2004.

C.4.b Please report your facility's actual performance.

Performance Data

Waste Management Method Baseline Year 1 Year 2 Year 3 Units

2003 2004 2005 2006

Reused/recycled off-site

Specify other:
3,249 1,982 398 6,929 Pounds

Specify other:

Incineration

Specify other:
98,840 130,875 96,800 53,051 Pounds

Specify other:

Other management

Specify other: Biological Treatment
4,263 80 0 443 Pounds

Specify other:

Other management

Specify other: Aqueous Inorganic Treatment
45 0 Pounds

Specify other:

Specify other:

Specify other:

C.4.c Summarized progress toward goal.

Actual Total Baseline Year 1 Year 2 Year 3 Perform.
Goal Units

Total Hazardous Waste 53.18 66.47 48.62 30.21 n/a Tons

Specify other:

Normalized Total Baseline Year 1 Year 2 Year 3 Perform.
Goal Units

Normalizing Factor 1.0 1.07 1.07 1.01

Total Hazardous Waste 53.18 62.12 45.44 29.91 52.11 Tons

Specify other:

Basis for your Normalizing Factor:
Normalizing factor shall be units produced in tablets.

C.4.e Please list any other EPA voluntary programs to which you are reporting these data.

Progress Towards Other Significant Aspects of your EMS

In the table below, please provide a narrative summary of progress made toward EMS objectives and targets other than those reported as Environmental Performance Commitments. You may limit the summary to environmental aspects that are significant and towards which progress has been made during the reporting year.

Do you have additional environmental aspects to report? Yes

Environmental Aspect Progress Made This Year (e.g., quantitative or qualitative improvements, activities conducted)

Remediation Project We have reach Maximun Contaminant Level's (MCL's) level at every monitoring well within the remediation project. And we are in the process of Post Monitoring Activities and Remediation Completion Stages. We expect to completed the remediation project by 3rd Quarter 2007

Attachments (if applicable) :

SECTION D: PUBLIC OUTREACH AND PERFORMANCE REPORTING

D.1 Please briefly describe the activities that your facility conducted during the year to interact with the community on environmental issues and to report publicly on environmental performance.

The facility provided a potable water tap for the benefit of the nearby communities since there are frequently periods of no service supply by the potable water provider (PRASA). We also provide maintenance to the public surrounding of the facility including a next by creek for the benefit of the adjacent community. The company contributed with funds and donated a piece of the property to allow the construction of a new connector as part of a bigger project which will reduce significantly the traffic passing thru downtown at peak hours. A local town resident called us to share their living condition affected by the overflow of sewage in their neighborhood and asking for advise on how to solve this situation.We visited the area and communicated the situation to local authorities (EQB state and regional office, EPA Caribbean Field Office, PRASA).J&J Publishes a Annual Report were they include the Environmental Performance Activity. At Janssen, Gurabo we maintain a open policy were any request for information on environmental performance will be authorize and provided tto any requestor.

D.2 Please indicate which of the following methods your facility plans to use to make its Performance Track Annual Performance Report available to the public. Please check all that apply.

Web Site
URL: http://http://www.jnj.com/community/environment/awards/index.htm

Attachments (if applicable):

OMB No. 2010-0032
SECTION E: SELF-CERTIFICATION OF CONTINUED PROGRAM PARTICIPATION FOR ANNUAL PERFORMANCE REPORT
The U.S. Environmental Protection Agency is not yet in a position to accept electronic signatures and therefore requests a faxed, signed copy of the Section E page. Please complete Section E online, then print Section E using the link on the Overview page. Section E should be signed by the senior manager of your facility and faxed it to the Performance Track Information Center at (617) 354-0463.
On behalf of Janssen Ortho LLC, I certify that: I have read and agree to the terms and conditions as specified in the National Enviromental Performance Track Program Guide. This facility, to the best of my knowledge, continues to meet all program criteria; I have personally examined and am familiar with the information contained in this Annual Performance Report. The information contained in this report is, to the best of my knowledge and based on reasonable inquiry, true, accurate, and complete; My facility has an environmental management system (EMS), as defined in the Performance Track EMS criteria, including systems to maintain compliance with all applicable federal, state, tribal, and local environmental requirements, in place at the facility, and the EMS will be maintained for the duration of the facility's participation in the program; My facility has conducted an objective assessment of its compliance with all applicable federal, state, tribal, and local environmental requirements; and the facility has corrected all identified instances of potential or actual noncompliance; and Based on the foregoing compliance assessments and subsequent corrective actions (if any were necessary), my facility is, to the best of my knowledge and based on reasonable inquiry, currently in compliance with applicable federal, state, tribal, and local environmental requirements. I agree that EPA's decision whether to accept participants into or remove them from the National Environment Performance Track is wholly discretionary, and I waive any right that may exist under any law to challenge EPA's acceptance or removal decision. I am the senior manager with responsibility for the facility and am fully authorized to execute this statement on behalf of the corporation or other legal entity whose facility is part of the National Environmental Performance Track program.
Signature/Date:	______________________________________________________
Name:	Mr. Ivan Cartagena
Title:	General Manager
Phone Number:	787-272-7600
E-Mail Address:	ICartage@janpr.jnj.com
Facility Name:	Janssen Ortho LLC
Facility Street Address:	Road 933 KM 0.1 Mamey Ward Gurabo, PR 00778-9629
Mailing Address:	,
Performance Track ID#:	A020020

B.3	Environmental Aspects Identification. When did your facility last conduct a systematic identification and/or review of your environmental aspects?
	October 06

Janssen Ortho LLC's first commitment is to reduce the facility's total water use.
C.1.a	Briefly describe your activities and achievements related to this commitment or, if relevant, any circumstances that delayed progress this year.
	We continued to reuse water from remediation project in our utilities such as cooling towers therefore avoiding potable water consumption. We also initiated the wastewater treatment plant water reuse project, which will allow us to reuse most of the WWTP discharge and consequently reducing the potable water usage. Normalization Factor is based on 4804MM Units produced in 2006 vs 4755MM Units produced in 2003
	Activities Conducted During 2005:	Approximately 40% of water discharge of the remediation treatment system have been reused internally for non-potable purposes. In addition, several projects (e.g., monitoring of water usage at different areas) and/or initiatives addressed to the reduction in water consumption were implemented.
	Activities Conducted During 2004:	Approximately 40% of water discharge of the remediation treatment system have been reused internally for non-potable purposes. In addition a revision of the water bills revealed that JOLLC was paying various invoices of facilities formerly use by Janssen. Various accounts were cancelled and credits received from the actual users. Normalization factor is based on 4755 MM Units produced in 2003 vs 5111 MM units produced in 2004.
C.1.b	Please report your facility's actual performance.

Performance Data
	Baseline	Year 1	Year 2	Year 3	Perform.
Calendar Year	2003	2004	2005	2006	Goal	Units
Actual Quantity (per year)	54,288,263	49,182,538	45,111,857	47,116,265	n/a	Gallons Specify other:

Normalized Total	Baseline	Year 1	Year 2	Year 3	Perform. Goal	Units
Normalizing Factor	1.0	1.07	1.07	1.01
Normalized Quantity	54,288,263	45,964,988.79	42,160,614.02	46,649,767.33	52,659,615	Gallons Specify other:
Basis for your Normalizing Factor:	The normalizing factor will be the tablets manufactured.

C.1.e	Please list any other EPA voluntary programs to which you are reporting these data.

Janssen Ortho LLC's second commitment is to reduce the facility's materials use. This data is aggregated with that of three other PSGA manfucturing facilities (Ortho Pharmaceutical and Ortho Biologics of Manati, PR and Ortho Pharmaceutical in Raritan, NJ). The data is included in the report for the Raritan facility.
C.2.a	Briefly describe your activities and achievements related to this commitment or, if relevant, any circumstances that delayed progress this year.
	The facility established a goal for 2007 on the EI metric and was agreed on by the facility's leadership group. This metric is presented on the staff meetings. Normalization factor is based on 4755 MM Units produced in 2003 vs 4804 MM Units produced in 2006
	Activities Conducted During 2005:	Site is focusing in the Design for the Environment (DfE) approach required by Johnson & Johnson for Planet 2010 Goals and the Efficiency Index (EI), which is a metric that takes into consideration the handling of materials received, quality control effective techniques/practices, manufacturing processes, storage of final products, etc. These practices and programs have been integrated within the Process Excellence initiatives. These initiatives seek for opportunities on process improvement, increase yield, reduce cycle time, control employee exposure and operating costs. Controlling all those have a positive impact in the site environmental performance. The Site's EI for Year 2005 was one of the highest's within the organization.
	Activities Conducted During 2004:	Site embraces the six sigma, lean thinking and design excellence approach. It is basically been integrated within the Process Excellence initiatives. This initiative seeks for opportunities on process improvement, increase yield, reduce cycle time, control employee exposure and operating costs. Controlling all those have a positive impact in the site environmental performance. Projects that have impact this goals are: Granulators yield improvement by 2-5%, Improvement in compressors stage thus eliminating rejects due to broken tablets, Automation of packaging lines, etc. Normalization factor is based on 4755 MM Units produced in 2003 vs 5111 MM units produced in 2004.
C.2.b	Please report your facility's actual performance.

C.2.e	Please list any other EPA voluntary programs to which you are reporting these data.

Janssen Ortho LLC's third commitment is to reduce the facility's generation of non-hazardous waste.
C.3.a	Briefly describe your activities and achievements related to this commitment or, if relevant, any circumstances that delayed progress this year.
	Disposable protection garments at the manufacturing area were replaced by reusable ones. This was part of a greenbelt project were cost avoidance was impacted significantly. Another activity for waste reduction is the reuse of empty fiber drums at other J&J facilities therefore avoiding discarting them. Normalization factor is based on 4755 MM Units produced in 2003 and 4804MM produced in 2006 Note: Waste to landfill for 2005 changed from 275,640 lbs to 1,095,630 lbs.
	Activities Conducted During 2005:	The site is identifying and implementing reuse and recycling processes that are helping the achievement of the reduction of non-hazardous waste disposal. In addition, since the Efficiency Index and the Design for the Environment initiatives are being implemented, this have aid in the reduction of waste associated with raw materials and others that indirectly are associated with the disposal of discarded materials (e.g., plastic bags, drums).
	Activities Conducted During 2004:	Although a slight increase in the overall volume of waste was experienced during this year, site made significant efforts in manageing the waste through environmental-friendly management methods. Over 45% increase in recyclables materials compare with year 2003. Overall waste managemet practices represents that 35.04% of our non-hazardous waste is managed by preferred management method as described by J&J (i.e. reuse, recycle, incineration with energy recovery, etc.) Normalization factor is based on 4755 MM Units produced in 2003 vs 5111 MM units produced in 2004.
C.3.b	Please report your facility's actual performance.

Performance Data
Waste Management Method	Baseline	Year 1	Year 2	Year 3	Units
Waste Management Method	2003	2004	2005	2006	Units
Reused/recycled off-site Specify other:	497,661	728,380	674,059	545,188	Pounds Specify other:
Incineration Specify other:	532,483	691,958	343,584	104,635	Pounds Specify other:
Landfill Specify other:	1,050,715	877,320	1,095,630	713,259	Pounds Specify other:
Other management Specify other: Biological Treatment	78,373	2,700	53,240	0	Pounds Specify other:
Other management Specify other:			0	0	Specify other:

Actual Total	Baseline	Year 1	Year 2	Year 3	Perform. Goal	Units
Total Non Hazardous Waste	1,079.62	1,150.18	1,083.26	681.54	n/a	Tons Specify other:

C.3.e	Please list any other EPA voluntary programs to which you are reporting these data.

Janssen Ortho LLC's fourth commitment is to reduce the facility's generation of hazardous waste.
C.4.a	Briefly describe your activities and achievements related to this commitment or, if relevant, any circumstances that delayed progress this year.
	We provide continuous awareness on waste minimization practices, pollution prevention and waste segregation as part of the orientations we provide to employees handleing HW.
	Activities Conducted During 2005:	A reduction in hazardous waste was due to the implementation of the Design for the Environment tool, the Efficiency Index, and the practice of weighting the materials instead of use the volumes of the different containers. DFE is a systematic process to identify and minimize the environmental impacts of products and processes throughout their entire life cycles. Has help the Environmental aspects in: Reducing risk; Reduce costs; Reduce time-to-profit; Eliminate the use of banned materials; Enhance Disassembly/Reuse/Recycle Gain competitive advantage. Efficiency Index or Ei, is an internal metric from the Pharmaceutical Sector within J&J, which is a way to measure how effectively we convert raw materials into finished goods. The ultimate goal is an Ei of 100%, which means that we are using all of our raw materials in our manufacturing processes with no waste. The closer we get to Ei 100 the better we are doing. Improving this metric we were able to reduce the generatioon of hazardous waste associated to cleaning process, such as Alcohol and rags, among others.
	Activities Conducted During 2004:	An increase in volume of operation have impacted the generation of hazardous waste at the site. Particularly the integration of Quality Assurance testing from other pharmaceutical facilities of PR into the Janssen Ortho LLC operation have impacted this measurement. This testings required usage of solvents that shall be disposed of as hazardous waste. Opportunities for improvement will be evaluated during this year. Normalization factor is based on 4755 MM Units produced in 2003 vs 5111 MM units produced in 2004.
C.4.b	Please report your facility's actual performance.

C.4.e	Please list any other EPA voluntary programs to which you are reporting these data.

D.1	Please briefly describe the activities that your facility conducted during the year to interact with the community on environmental issues and to report publicly on environmental performance.
	The facility provided a potable water tap for the benefit of the nearby communities since there are frequently periods of no service supply by the potable water provider (PRASA). We also provide maintenance to the public surrounding of the facility including a next by creek for the benefit of the adjacent community. The company contributed with funds and donated a piece of the property to allow the construction of a new connector as part of a bigger project which will reduce significantly the traffic passing thru downtown at peak hours. A local town resident called us to share their living condition affected by the overflow of sewage in their neighborhood and asking for advise on how to solve this situation.We visited the area and communicated the situation to local authorities (EQB state and regional office, EPA Caribbean Field Office, PRASA).J&J Publishes a Annual Report were they include the Environmental Performance Activity. At Janssen, Gurabo we maintain a open policy were any request for information on environmental performance will be authorize and provided tto any requestor.
D.2	Please indicate which of the following methods your facility plans to use to make its Performance Track Annual Performance Report available to the public. Please check all that apply.
	Web Site
	URL: http://http://www.jnj.com/community/environment/awards/index.htm
	Attachments (if applicable):

SECTION A: GENERAL FACILITY INFORMATION

Section B: ENVIRONMENTAL MANAGEMENT SYSTEM

SECTION C: ENVIRONMENTAL PERFORMANCE RESULTS

C.1 COMMITMENT 1

C.2 COMMITMENT 2

C.3 COMMITMENT 3

C.4 COMMITMENT 4

SECTION D: PUBLIC OUTREACH AND PERFORMANCE REPORTING

SECTION E: SELF-CERTIFICATION OF CONTINUED PROGRAM PARTICIPATION FOR ANNUAL PERFORMANCE REPORT